Vickers Vantage Corp. I (VCKAW) operates as a Cayman Islands exempted blank check company whose securities, including warrants, continue to trade post its 2022 business combination with Scilex Holding Company; it provides no independent products or services beyond its SPAC structure for mergers, share exchanges, asset acquisitions, share purchases, recapitalizations, reorganizations, or similar transactions with one or more target businesses. Headquartered in Singapore and founded in 2020, the company, led by Chairman and CEO Jeffrey Chi, targeted opportunities across industries and geographies without limitation, issuing common stock (VCKA), units (VCKAU), and warrants (VCKAW) through its NASDAQ-listed IPO. In March 2022, it entered a definitive business combination agreement with Scilex Holding Company, a biopharmaceutical developer of non-opioid pain treatments, which closed via shareholder approval on November 9, 2022, resulting in Scilex listing as SCLX/SCLXW while VCKAW warrants persist for potential common share purchases upon exercise conditions.